Candriam SCA’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-30,765
| Closed | -$1.78M | – | 832 |
|
2019
Q2 | $1.78M | Buy |
30,765
+3,400
| +12% | +$197K | 0.02% | 535 |
|
2019
Q1 | $1.92M | Buy |
27,365
+9,616
| +54% | +$674K | 0.02% | 508 |
|
2018
Q4 | $1.14M | Buy |
17,749
+749
| +4% | +$48.2K | 0.02% | 563 |
|
2018
Q3 | $1.19M | Sell |
17,000
-23,000
| -58% | -$1.62M | 0.02% | 591 |
|
2018
Q2 | $2.02M | Sell |
40,000
-34,000
| -46% | -$1.71M | 0.03% | 485 |
|
2018
Q1 | $2.32M | Sell |
74,000
-15,000
| -17% | -$469K | 0.04% | 449 |
|
2017
Q4 | $3.04M | Sell |
89,000
-10,000
| -10% | -$342K | 0.05% | 374 |
|
2017
Q3 | $3.18M | Hold |
99,000
| – | – | 0.06% | 366 |
|
2017
Q2 | $3.22M | Buy |
99,000
+4,000
| +4% | +$130K | 0.06% | 361 |
|
2017
Q1 | $2.99M | Buy |
95,000
+8,000
| +9% | +$252K | 0.06% | 366 |
|
2016
Q4 | $2.56M | Buy |
87,000
+8,000
| +10% | +$235K | 0.06% | 321 |
|
2016
Q3 | $2.29M | Buy |
79,000
+16,000
| +25% | +$463K | 0.06% | 334 |
|
2016
Q2 | $1.63M | Sell |
63,000
-37,000
| -37% | -$958K | 0.04% | 346 |
|
2016
Q1 | $2.46M | Sell |
100,000
-28,000
| -22% | -$690K | 0.06% | 292 |
|
2015
Q4 | $4.51M | Sell |
128,000
-46,400
| -27% | -$1.63M | 0.12% | 192 |
|
2015
Q3 | $3.69M | Sell |
174,400
-9,600
| -5% | -$203K | 0.09% | 245 |
|
2015
Q2 | $5.11M | Buy |
184,000
+73,000
| +66% | +$2.03M | 0.11% | 237 |
|
2015
Q1 | $3.39M | Sell |
111,000
-9,000
| -8% | -$275K | 0.07% | 316 |
|
2014
Q4 | $3.84M | Buy |
+120,000
| New | +$3.84M | 0.08% | 280 |
|